 |
|
'Chemical Hyperthyroidism'Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated With Levothyroxine
Duncan Salmon, MD;
Marc Rendell, MD;
Julia Williams;
Cynthia Smith, MPH;
David A. Ross, ScD;
John M. Waud, PhD;
John Eager Howard, MD
Arch Intern Med. 1982;142(3):571-573.
Abstract
• We have observed many patients treated with levothyroxine sodium who have elevated serum thyroxine (T4) levels but appear clinically euthyroid. Such patients generally have normal serum triiodothyronine (T3) values. A retrospective review at The Johns Hopkins Hospital, Baltimore, comparing the correlation of T3 and T4 values in levothyroxine-treated patients with that in patients not so treated was carried out from 1977 to 1979. Mean free thyroxine index (FTI) value in 104 levothyroxine-treated patients was 4.70 ± 0.2 and mean T3 value was 177 ± 9 ng/dL. In a group of 50 hyperthyroid patients, mean FTI value was 7.26 ± 0.5, with a mean T3 value of 389 ± 26 ng/dL. In 71 euthyroid patients, mean FTI value was 2.36 ± 0.1, with a T3 value of 137 ± 3 ng/dL. Computed ratios of T3 to FTI and T3 to T4 were significantly lower in the group treated with levothyroxine than in either the hyperthyroid or euthyroid nontreated groups. Levothyroxine-treated patients with high T4 levels but normal T3 levels were clinically euthyroid. Patients not treated with levothyroxine with similarly elevated T4 levels had elevated T3 levels and were clinically hyperthyroid. It is concluded that lower relative T3 levels in levothyroxine-treated patients may explain why these patients appear clinically euthyroid despite elevated T4 values. Serum T3 determination is the procedure of choice for evaluation of levothyroxine-treated individuals. Furthermore, an elevated FTI value in such an individual does not, in itself, dictate need to reduce dosage.
(Arch Intern Med 1982;142:571-573)
Author Affiliations
From the Departments of Medicine (Drs Salmon, Rendell, and Howard) and Nuclear Medicine (Drs Rendell and Waud), The Johns Hopkins Hospital; and the Departments of Health Services Research (Mss Smith and Williams and Dr Ross) and Medicine (Drs Salmon and Rendell), the US Public Health Service Hospital, Baltimore.
Footnotes
Accepted for publication Oct 22, 1981.
Reprint requests to Division of Endocrinology, Department of Medicine, Blalock 909, The Johns Hopkins Hospital, 725 N Wolfe St, Baltimore, MD 21205 (Dr Rendell).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Evidence of Hyperthyroidism in Apparently Euthyroid Patients Treated With Levothyroxine
Banovac et al.
Arch Intern Med 1989;149:809-812.
ABSTRACT
Hyperthyroxinemia in Patients Receiving Thyroid Replacement Therapy
Grund and Niewoehner
Arch Intern Med 1989;149:921-924.
ABSTRACT
Serum Angiotensin-Converting Enzyme: Alterations in Hyperthyroidism, Hypothyroidism, and Subacute Thyroiditis
Smallridge et al.
JAMA 1983;250:2489-2493.
ABSTRACT
Euthyroid Hyperthyroxinemia
BORST et al.
ANN INTERN MED 1983;98:366-378.
ABSTRACT
|
